C. De Gislain
- Genetics top 10%
- Public Health, Environmental and Occupational Health top 10%
- Dermatology top 5%
- Oncology
- Pulmonary and Respiratory Medicine
- Topics
- Chemotherapy-induced organ toxicity mitigation (4 papers)Brain Metastases and Treatment (2 papers)Endometrial and Cervical Cancer Treatments (2 papers)
In The Last Decade
C. De Gislain
14 papers receiving 425 citations
Peers
Comparison fields: 5 of 42
- Genetics 192
- Public Health, Environmental and Occupational Health 176
- Dermatology 141
- Oncology 137
- Pulmonary and Respiratory Medicine 116
Countries citing papers authored by C. De Gislain
This map shows the geographic impact of C. De Gislain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. De Gislain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. De Gislain more than expected).
Fields of papers citing papers by C. De Gislain
This network shows the impact of papers produced by C. De Gislain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. De Gislain. The network helps show where C. De Gislain may publish in the future.
Co-authorship network of co-authors of C. De Gislain
This figure shows the co-authorship network connecting the top 25 collaborators of C. De Gislain. A scholar is included among the top collaborators of C. De Gislain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. De Gislain. C. De Gislain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 104 | |
| 2 | 20 | |
| 3 | [Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles]. | 1 |
| 4 | [Leukemia and pre-leukemic conditions occurring after treatment of breast cancer]. | 6 |
| 5 | 80 | |
| 6 | 0 | |
| 7 | 164 | |
| 8 | 2 | |
| 9 | 12 | |
| 10 | [Course of blood creatinine during repeated injections of cisplatin. Influence of drug combinations]. | 3 |
| 11 | 16 | |
| 12 | 12 | |
| 13 | Facteurs de récidive précoce des cancers du sein sans envahissement ganglionnaire axillaire (N | 1 |
| 14 | 11 | |
| 15 | Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II). | 9 |
About C. De Gislain
C. De Gislain is a scholar working on Pathology and Forensic Medicine, Obstetrics and Gynecology and Otorhinolaryngology, having authored 15 papers that have together received 441 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (4 papers), Brain Metastases and Treatment (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Dermatology (141 citations), Obstetrics and Gynecology (60 citations) and Genetics (192 citations). C. De Gislain has collaborated with scholars based in France, Germany and Tunisia. Frequent co-authors include B. Cutuli, B. De Lafontan, J Berlié, C. Marchal, J Guerrin, Érick Gamelin, F. Campana, Michel Héry, Y Graïc and M Lacroze. Their work appears in journals such as International Journal of Cancer, European Journal of Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.